SCHEMBL23518949

SCHEMBL23518949

O=C(Oc1ccc(O)cc1)c1ccc(OC(F)(F)C(=O)O)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PARP10 Q53GL7 1/20 0.45
▸ ELANE P08246 1/20 0.44
▸ MAPT P10636 1/20 0.43
▸ TDP1 Q9NUW8 1/20 0.43
▸ L3MBTL1 Q9Y468 1/20 0.43
▸ PRSS1 P07477 2/20 0.43
▸ ACR P10323 1/20 0.43
▸ HSD17B10 Q99714 2/20 0.42
▸ SENP1 Q9P0U3 1/20 0.41
▸ NSD2 O96028 1/20 0.41
▸ AURKA O14965 1/20 0.41
▸ TPX2 Q9ULW0 1/20 0.41
▸ KMT2A Q03164 3/20 0.41
▸ MEN1 O00255 1/20 0.41
▸ CA12 O43570 1/20 0.41
▸ CA1 P00915 1/20 0.41
▸ CA2 P00918 1/20 0.41
▸ CA7 P43166 1/20 0.41
▸ CA9 Q16790 1/20 0.41
▸ CA14 Q9ULX7 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23518959 0.89 PARP10 (0.54) PARP10MAPTTDP1L3MBTL1PRSS1
SCHEMBL13560798 0.87 AURKA (0.49) PARP10ELANEPRSS1ACRHSD17B10
SCHEMBL14145709 0.87 AURKA (0.49) PARP10ELANEPRSS1ACRHSD17B10
SCHEMBL23519216 0.86 LMNA (0.54) PARP10MAPTTDP1L3MBTL1PRSS1
SCHEMBL24360977 0.85 LMNA (0.52) ELANEMAPTTDP1L3MBTL1HSD17B10
SCHEMBL24361271 0.82 MEN1 (0.52) PARP10ELANEAURKATPX2KMT2A
SCHEMBL16493489 0.81 HSD17B10 (0.59) PARP10ELANEMAPTPRSS1HSD17B10
SCHEMBL688276 0.81 HSD17B10 (0.59) PARP10ELANEMAPTPRSS1HSD17B10
SCHEMBL9696072 0.81 HSD17B10 (0.59) PARP10ELANEMAPTPRSS1HSD17B10
SCHEMBL740606 0.81 HSD17B10 (0.59) PARP10ELANEMAPTPRSS1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210179554-A1 ONIUM SALT COMPOUND, CHEMICALLY AMPLIFIED RESIST COMPOSITION AND PATTERNING PROCESS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2021-06-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210179554-A1 ONIUM SALT COMPOUND, CHEMICALLY AMPLIFIED RESIST COMPOSITION AND PATTERNING PROCESS SLC6A5, LIFR, SLC6A9 PARP10 3960/4885ELANE 2738/4885MAPT 2273/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback